Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti-PD-1 Immunotherapy.
Liu Y, Wang H, Zhao X, Zhang J, Zhao Z, Lian X, Zhang J, Kong F, Hu T, Wang T, Li X, Wang L, Wang D, Li C, Luan H, Liu X, Wang C, Jiang Y, Li X, Li F, Ji S, Wang Y, Li Z.
Liu Y, et al. Among authors: wang h, wang l, wang y, wang t, wang d, wang c.
Cancer Res. 2023 Oct 13;83(20):3385-3399. doi: 10.1158/0008-5472.CAN-22-3115.
Cancer Res. 2023.
PMID: 37506192